JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2024, 73(2):e1-e14 | DOI: 10.36290/csf.2024.019

Auxiliary drugs (benzodiazepines, opioid analgesics, presynaptic α2-adrenergic receptor agonists, peripheral myorelaxants) used in general anesthesia

Ružena Čižmáriková, Ladislav Habala, Jindra Valentová
Katedra chemickej teórie liečiv, Farmaceutická fakulta UK v Bratislave

This review represents a continuation of the already published surveys on substances used in local, general inhalational, and intravenous anesthesia. The administration of a single active substance in these applications is rare, as it is not capable of inducing anesthesia without seriously compromising hemodynamic or respiratory functions, aggravating the operating conditions, or delaying the postoperative recovery. For this reason, other agents (benzodiazepines, opioid analgesics, presynaptic α2-adrenergic receptor agonists and peripheral myorelaxants) are standard components of general anesthesia (in addition to the anesthetic agents listed in the previous reviews), which improve the profile of each anesthetic agent. Each additive has an effect on the properties of the anesthetics used. The review contains the characteristics of individual groups of co-administered substances with their chemical structure, chemical IUPAC name, and pharmacological and pharmacokinetic profile. Chemical structures are organized into groups according to their structure or pharmacological effect and attention is also paid to their stereochemistry (presence of stereogenic center, chair form of cyclic systems).

Keywords: anesthetics, benzodiazepines, opioid analgesics, presynaptic α2-adrenergic receptor agonists, peripheral myorelaxants.

Accepted: June 12, 2024; Published: June 14, 2024  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Čižmáriková R, Habala L, Valentová J. Auxiliary drugs (benzodiazepines, opioid analgesics, presynaptic α2-adrenergic receptor agonists, peripheral myorelaxants) used in general anesthesia. Čes. slov. farm. 2024;73(2):e1-14. doi: 10.36290/csf.2024.019.
Download citation

References

  1. Vuyk J. Drug interactions in anaesthesia. Minerva Anestesiol. 1999;65(5):215-218.
  2. Čižmáriková R, Čižmárik J, Valentová J, Habala L, Markuliak M. Chiral aspects of local anesthetics. Molecules 2020;25(12):2738. Go to original source... Go to PubMed...
  3. Čižmáriková R, Habala L, Markuliak M. Celkové inhalačné anestetiká - farmakodynamika, farmakokinetika a chirálne vlastnosti. Čes slov Farm. 2021;70(1):7-17. Go to original source...
  4. Čižmáriková R, Habala L, Markuliak M. Celkové intravenózne anestetiká - farmakodynamika, farmakokinetika a chirálne vlastnosti. Čes slov Farm. 2023;72(4):155-164. Go to original source...
  5. Möhler H, Fritschy JM, Rudolph U. A new benzodiazepine pharmacology. J Pharmacol Exp Ther. 2002;300(1):2-8. Go to original source... Go to PubMed...
  6. Balon R, Starcevic V. Role of benzodiazepines in anxiety disorders. Adv Exp Med Biol. 2020;1191:367-388. Go to original source... Go to PubMed...
  7. Miranda Seixas Einloft F, Kopittke L, Thais Guterres Dias M, Luana Veriato Schultz Á, Maria Dotta R, Maria Tannhauser Barros H. The use of benzodiazepines and the mental health of women in prison: a cross-sectional study. Sci Rep. 2023;13(1):4491. Go to original source... Go to PubMed...
  8. Atack JR. Anxioselective compounds acting at the GABA(A) receptor benzodiazepine binding site. Curr Drug Targets CNS Neurol Disord. 2003;2(4):213-232. Go to original source... Go to PubMed...
  9. Atack JR. The benzodiazepine binding site of GABA(A) receptors as a target for the development of novel anxiolytics. Expert Opin Investig Drugs. 2005;14(5):601-618. Go to original source... Go to PubMed...
  10. Baur R, Tan KR, Luscher BP, Gonthier A, Goeldner M, Sigel E. Covalent modification of GABAA receptor isoforms by a diazepam analogue provides evidence for a novel benzodiazepine binding site that prevents modulation by these drugs. J Neurochem. 2008;106:2353-2363. Go to original source... Go to PubMed...
  11. Sigel E, Steinmann ME. Structure, function, and modulation of GABA(A) receptors. J Biol Chem. 2012;287(48):40224-40231. Go to original source... Go to PubMed...
  12. Zhu S, Noviello CM, Teng J, Walsh RM Jr, Kim JJ, Hibbs RE. Structure of a human synaptic GABAA receptor. Nature 2018;559(7712):67-72. Go to original source... Go to PubMed...
  13. Kim JJ, Gharpure A, Teng J, Zhuang Y, Howard RJ, Zhu S, Noviello CM, Walsh RM Jr, Lindahl E, Hibbs RE. Shared structural mechanisms of general anaesthetics and benzodiazepines. Nature 2020;585(7824):303-308. Go to original source... Go to PubMed...
  14. Flumazenil. [Internet]. [cited 2024 Feb 23]. Available from: https://www.sukl.sk/hlavna-stranka/slovenska-verzia/pomocne-stranky/detail-lieku?page_id=386 & lie_id=53545.
  15. Adachi YU, Watanabe K, Higuchi H, Satoh T. Flumazenil reduces the hypnotic dose of propofol in male patients under spinal anesthesia. J Anesth. 2002;16:9-12. Go to original source... Go to PubMed...
  16. Hess L, Málek J, Schreiberová J. Specifický antagonista benzodiazepinů flumazenil na začátku 21. století - je vůbec zapotřebí? Anest Intenziv Med. 2006;17(6):295-298.
  17. Diazepam (PIM 181). [Internet]. [cited 2024 Feb 23]. Available from: https://inchem.org/documents/pims/pharm/pim181.htm.
  18. Diazepam hydrochloride. [Internet]. [cited 2024 Feb 23]. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/Diazepam-hydrochloride.
  19. Taukulis HK, Fillmore MT, Ruggles JL. Neuroleptic-induced changes in the anxiolytic and myorelaxant properties of diazepam in the rat. Pharmacol Biochem Behav. 1992;41(1):13-21. Go to original source... Go to PubMed...
  20. Crestani F, Löw K, Keist R, Mandelli M, Möhler H, Rudolph U. Molecular targets for the myorelaxant action of diazepam. Mol Pharmacol. 2001;59(3):442-445. Go to original source... Go to PubMed...
  21. Høgskilde S, Nielsen JW, Carl P, Angelo H, Bredgaard Sørensen M. The anticonvulsive activity and toxicity of diazepam in three different formulations. An experimental study in mice. Acta Anaesthesiol Scand. 1987;31(4):289-291. Go to original source... Go to PubMed...
  22. Weintraub SJ. Diazepam in the treatment of moderate to severe alcohol withdrawal. CNS Drugs 2017;31(2):87-95. Go to original source... Go to PubMed...
  23. Dionne RA, Goldstein DS, Wirdzek PR. Effects of diazepam premedication and epinephrine-containing local anesthetic on cardiovascular and plasma catecholamine responses to oral surgery. Anesth Analg. 1984;63(7):640-646. Go to original source...
  24. Ho TT, Noble M, Tran BA, Sunjic K, Gupta SV, Turgeon J, Crutchley RD. Clinical impact of the CYP2C19 gene on diazepam for the management of alcohol withdrawal syndrome. J Pers Med. 2023;13(2):285. Go to original source... Go to PubMed...
  25. Temazepam. [Internet]. [cited 2024 Feb 23]. Available from: https://www.drugs.com/temazepam.htm.
  26. Temazepam. [Internet]. [cited 2024 Feb 23]. Available from: https://www.healthdirect.gov.au/temazepam.
  27. Midazolam. [Internet]. [cited 2024 Feb 23]. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/Midazolam.
  28. Midazolam Kalceks. [Internet]. [cited 2024 Feb 23]. Available from: https://www.olikla.cz/data/2022/06/20/09/midazolam-kalceks-spc_9_12_2021.pdf (23. 2. 2024).
  29. O'Neil MJ (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Cambridge, UK: Royal Society of Chemistry; 2013. p. 1147.
  30. Stevanović P. [Midazolam (dormicump)--clinical practice guidelines]. Med Pregl. 2006;59(1-2):89-94. Go to original source... Go to PubMed...
  31. Chen Q, Wang L, Ge L, Gao Y, Wang H. The anxiolytic effect of midazolam in third molar extraction: a systematic review. PLoS One 2015;10(4):e0121410. Go to original source... Go to PubMed...
  32. Dhir A, Rogawski MA. Role of neurosteroids in the anticonvulsant activity of midazolam. Br J Pharmacol. 2012;165(8):2684-2691. Go to original source... Go to PubMed...
  33. Midazolam - an overview. [Internet]. [cited 2024 Feb 23]. Available from: https://www.sciencedirect.com/topics/chemistry/midazolam.
  34. Singhi S, Murthy A, Singhi P, Jayashree M. Continuous midazolam versus diazepam infusion for refractory convulsive status epilepticus. J Child Neurol. 2002;17(2):106-110. Go to original source... Go to PubMed...
  35. Koul R, Chacko A, Javed H, Al Riyami K. Eight-year study of childhood status epilepticus: midazolam infusion in management and outcome. J Child Neurol. 2002;17:908-910. Go to original source...
  36. Bellante F, Legros B, Depondt C, Créteur J, Taccone FS, Gaspard N. Midazolam and thiopental for the treatment of refractory status epilepticus: a retrospective comparison of efficacy and safety. J Neurol. 2016;263(4):799-806. Go to original source... Go to PubMed...
  37. Kotlinska-Lemieszek A. Should midazolam drug-drug interactions be of concern to palliative care physicians? Drug Safety 2013;36:789-790. Go to original source... Go to PubMed...
  38. Khanderia U, Pandit SK. Use of midazolam hydrochloride in anesthesia. Clin Pharm 1987;6(7):533-547.
  39. Valentine JM, Lyons G, Bellamy MC. The effect of intrathecal midazolam on post-operative pain. Eur J Anaesthesiol. 1996;13:589-593. Go to original source... Go to PubMed...
  40. Bharti N, Madan R, Mohanty PR, Kaul HL. Intrathecal midazolam added to bupivacaine improves the duration and quality of spinal anaesthesia. Acta Anaesthesiol Scand. 2003;47:1101-1105. Go to original source... Go to PubMed...
  41. Yun MJ, Kim YH, Kim JH, Kim KO, Oh AY, Park HP. Intrathecal midazolam added to bupivacaine prolongs the duration of spinal blockade to T10 dermatome in orthopedic patients. Korean J Anesthesiol. 2007;53:S22-S28. Go to original source...
  42. Mandema JW, Tuk B, van Steveninck AL, Breimer DD, Cohen AF, Danhof M. Pharmacokinetic-pharmacodynamic modelling of the central nervous system effects of midazolam and its main metabolite α-hydroxymidazolam in healthy volunteers. Clin Pharmacol Ther. 1992;51:715-728. Go to original source... Go to PubMed...
  43. Wandel C, Bocker R, Bohrer H, Browne A, Rugheimer E, Martin E. Midazolam is metabolized by at least three different cytochrome P450 enzymes. Br J Anaesth. 1994;73:658-661. Go to original source... Go to PubMed...
  44. Johnson TN, Rostami-Hodjegan A, Goddard JM, Tucker GT. Contribution of midazolam and its 1-hydroxy metabolite to preoperative sedation in children: a pharmacokinetic-pharmacodynamic analysis. Br J Anaest. 2002;89(3):428-437. Go to original source...
  45. Lorazepam. [Internet]. [cited 2024 Feb 23]. Available from: http://www.chemspider.com/Chemical-Structure.3821.html.
  46. Lorazepam. [Internet]. [cited 2024 Feb 23]. Available from: https://www.gelbe-liste.de/wirkstoffe/Lorazepam_387.
  47. Lorazepam. [Internet]. [cited 2024 Feb 23]. Available from: https://go.drugbank.com/drugs/DB00186.
  48. Fişgin T, Gürer Y, Senbil N, Teziç T, Zorlu P, Okuyaz C, Akgün D. Nasal midazolam effects on childhood acute seizures. J Child Neurol. 2000;15(12):833-835. Go to original source... Go to PubMed...
  49. Ramanujam R, Padma L, Swaminath G, Thimmaiah RS. A comparative study of the clinical efficacy and safety of Lorazepam and chlordiazepoxide in alcohol dependence syndrome. J Clin Diagn Res. 2015;9(3):FC10-13. Go to original source... Go to PubMed...
  50. Gonzalez J, Upadhyaya VD, Manna ZT, Sharma AR, Christopher J, Douedi S, Sen S. Paradoxical excitation following intravenous lorazepam administration for alcohol withdrawal - a case presentation and literature review. J Pharm Pract. 2023;36(5):1244-1248. Go to original source... Go to PubMed...
  51. Lin CC, Huang TL. Lorazepam-diazepam protocol for catatonia in schizophrenia: a 21-case analysis. Compr Psychiatry. 2013;54(8):1210-1214. Go to original source... Go to PubMed...
  52. Cevher Binici N, Topal Z, Demir Samurcu N, Cansiz MA, Savci U, Öztürk Y, Özyurt G, Tufan AE. Response of catatonia to amisulpride and lorazepam in an adolescent with schizophenia. J Child Adolesc Psychopharmacol. 2018;28(2):151-152. Go to original source... Go to PubMed...
  53. Amini A, Heidari K, Asadollahi S, Habibi T, Shahrami A, Mansouri B, Kariman H. Intravenous promethazine versus lorazepam for the treatment of peripheral vertigo in the emergency department: A double blind, randomized clinical trial of efficacy and safety. J Vestib Res. 2014;24(1):39-47. Go to original source... Go to PubMed...
  54. Gardner K. Lorazepam for sleep: Can lorazepam help with sleep? In: singlecare.com [Internet]. 2023 Jun 16 [cited 2024 Feb 23]. Available from: https://www.singlecare.com/blog/lorazepam-for-sleep.
  55. Kotegawa T, Tsutsumi K, Imai H, Ohashi K, Nakano S. The effect of experimentally induced sleep disturbance on the pharmacokinetics of lorazepam in healthy volunteers. Int J Clin Pharmacol Ther. 2014;52(6):519-524. Go to original source... Go to PubMed...
  56. Dundee JW, Lilburn JK, Nair SG, George KA. Studies of drugs given before anaesthesia XXVI: lorazepam. Br J Anaesth. 1977;49(10):1047-1056. Go to original source... Go to PubMed...
  57. Lorazepam. [Internet]. [cited 2024 Feb 23]. Available from: https://go.drugbank.com/drugs/DB00186.
  58. Chlordiazepoxide. [Internet]. [cited 2024 Feb 23]. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/Chlordiazepoxide.
  59. Chlordiazepoxide hydrochloride. [Internet]. [cited 2024 Feb 23]. Available from: https://go.drugbank.com/salts/DBSALT000632.
  60. López-Muñoz F, Alamo C, García-García P. The discovery of chlordiazepoxide and the clinical introduction of benzodiazepines: half a century of anxiolytic drugs. J Anxiety Disord. 2011;25(4):554-562. Go to original source... Go to PubMed...
  61. Rajmohan V, Sushil K, Mohandas E. A double blind randomised comparison of chlordiazepoxide and lorazepam in alcohol withdrawal. Asian Psychiatr. 2013;6(5),401-403. Go to original source... Go to PubMed...
  62. Boxenbaum HG, Geitner KA, Jack ML, Dixon WR, Kaplan SA. Pharmacokinetic and biopharmaceutic profile of chlordiazepoxide HC1 in healthy subjects: multiple-dose oral administration. J Pharmacokinet Biopharm. 1977;5:25-39. Go to original source... Go to PubMed...
  63. Ghiasi N, Bhansali RK, Marwaha R. Lorazepam | StatPearls. [Internet]. [cited 2024 Feb 23]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK532890/.
  64. Christensen P, Lolk A, Gram LF, Kragh-Sørensen P. Benzodiazepine-induced sedation and cortisol suppression. A placebo-controlled comparison of oxazepam and nitrazepam in healthy male volunteers. Psychopharmacol. 1992,106(4):511-516. Go to original source... Go to PubMed...
  65. Oxazepam. [Internet]. [cited 2024 Feb 23]. Available from: https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/oxazepam.
  66. Singh R, Abdijadid S. Oxazepam | StatPearls. In: ncbi.nlm.nih.gov [Internet]. 2023 May 22 [cited 2024 Feb 23]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK544349/.
  67. Oxazepam: 7 things you should know. [Internet]. [cited 2024 Feb 23]. Available from: https://www.drugs.com/tips/oxazepam-patient-tips.
  68. Sonne J, Loft S, Døssing M, Vollmer-Larsen A, Olesen KL, Victor M, Andreasen F, Andreasen PB. Bioavailability and pharmacokinetics of oxazepam. Eur J Clin Pharmacol. 1988;35:385-389. Go to original source... Go to PubMed...
  69. Dinis-Oliveira RJ. Metabolic profile of oxazepam and related benzodiazepines: clinical and forensic aspects. Drug Metab Rev. 2017;49(4):451-463. Go to original source... Go to PubMed...
  70. Aso Y, Yoshioka S, Shibazaki T, Uchiyama M. Chem Pharm Bull. 1988;36(5):1834-1840. Go to original source... Go to PubMed...
  71. Hok L, Božičević L, Sremec H, Šakić D, Vrček V. Racemization of oxazepam and chiral 1,4-benzodiazepines. DFT study of the reaction mechanism in aqueous solution. Org Biomol Chem. 2019;17(6),1471-1479. Go to original source... Go to PubMed...
  72. Nitrazepam. [Internet]. [cited 2024 Feb 23]. Available from: https://www.chemicalbook.com/ChemicalProductProperty_EN_CB8338260.htm.
  73. Nitrazepam. [Internet]. [cited 2024 Feb 23]. Available from: https://go.drugbank.com/drugs/DB01595.
  74. Konishi K, Fukami T, Gotoh S, Nakajima M. Identification of enzymes responsible for nitrazepam metabolism and toxicity in human. Biochem Pharmacol. 2017;140:150-160. Go to original source... Go to PubMed...
  75. Sneyd JR. Remimazolam - current status, opportunities and challenges. Anesthesiology and Perioperative Science 2023;1:25. Go to original source...
  76. Tamatam R, Shin D. Asymmetric synthesis of US-FDA approved drugs over five years (2016-2020): A recapitulation of chirality. Pharmaceuticals (Basel) 2023;16(3):339. Go to original source... Go to PubMed...
  77. Sneyd JR, Rigby-Jones AE. Remimazolam for anaesthesia or sedation. Curr Opin Anaesthesiol. 2020;33(4):506-511. Go to original source... Go to PubMed...
  78. Lee A, Shirley M. Remimazolam: A review in procedural sedation. Drugs 2021;81(10):1193-1201. Go to original source... Go to PubMed...
  79. Pedersen MH, Danø A, Englev E, Kattenhøj L, Munk E. Economic benefits of remimazolam compared to midazolam and propofol for procedural sedation in colonoscopies and bronchoscopies. Curr Med Res Opin. 2023;39(5),691-699. Go to original source... Go to PubMed...
  80. Hu B, Zhang M, Wu Z, Zhang X, Zou X, Tan L, Song T, Li X. Comparison of remimazolam tosilate and etomidate on hemodynamics in cardiac surgery: a randomised controlled trial. Drug Des Devel Ther. 2023;17:381-388. Go to original source... Go to PubMed...
  81. Remimazolam. [Internet]. [cited 2024 Feb 23]. Available from: https://www.sciencedirect.com/topics/medicine-and-dentistry/remimazolam.
  82. Opioidy (pediatrie) | WikiSkripta. [Internet]. [cited 2024 Feb 23]. Available from: https://www.wikiskripta.eu/w/Opioidy_(pediatrie) (23. 2. 2024).
  83. Lejčko J. Přehled opioidních analgetik. Prakt lékáren [online] 2009;4:172-175.
  84. Schäfer M, Zöllner C. Opioide in der Anästhesiologie. Die Anästhesiologie. In: springermedizin.de/emedpedia [Internet]. 2017 May 3 [cited 2024 Feb 23]. Available from: https://www.springermedizin.de/emedpedia/detail/die-anaesthesiologie/opioide-in-der-anaesthesiologie?epediaDoi=10.1007%2F978-3-662-45539-5_20.
  85. Naloxone hydrochloride. [Internet]. [cited 2024 Feb 23]. Available from: https://www.fishersci.com/shop/products/naloxone-hydrochloride-98-thermo-scientific/AAJ60013MC.
  86. Naloxone Hydrochloride. [Internet]. [cited 2024 Feb 23]. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/Naloxone-hydrochloride.
  87. Naloxone. [Internet]. [cited 2024 Feb 23]. Available from: https://www.sciencedirect.com/topics/neuroscience/naloxone.
  88. Fentanyl. [Internet]. [cited 2024 Feb 23]. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/fentanyl
  89. Abo El Enin MA, Amin IE, Abd El Aziz AS, Mahdy MM, Abo El Enin MA, Mostafa MM. Effect of fentanyl addition to local anaesthetic in peribulbar block. Indian J Anaesth. 2009;53(1):57-63.
  90. Mercadante S, Adile C, Cuomo A, Aielli F, Cortegiani A, Casuccio A, Porzio G. Fentanyl buccal tablet vs. oral morphine in doses proportional to the basal opioid regimen for the management of breakthrough cancer pain: a randomized, crossover, comparison study. J Pain Symptom Manag. 2015;50(5):579-586. Go to original source... Go to PubMed...
  91. Kwon MY, Lee MY, Han YJ, Lee SH, Kim EJ, Park S, Lee YG, Koo DH. Predicting tolerability of high-dose fentanyl buccal tablets in cancer patients. PLoS One 2023;18(1):e0280212. Go to original source... Go to PubMed...
  92. Darlong V, Som A, Baidya DK, Pandey R, Punj J, Pande A. Effect of varying time intervals between fentanyl and propofol administration on propofol requirement for induction of anaesthesia: Randomised controlled trial. Indian J Anaesth. 2019;63(10):827-833. Go to original source... Go to PubMed...
  93. Feierman DE, Lasker JM. Metabolism of fentanyl, a synthetic opioid analgesic, by human liver microsomes. Role of CYP3A4. Drug Metab Dispos. 1996;24(9):932-939. Go to original source...
  94. Feierman DE. Identification of cytochrome P450 3A1/2 as the major P450 isoform responsible for the metabolism of fentanyl by rat liver microsomes. Anesth Analg. 1996;82(5):936-941. Go to original source... Go to PubMed...
  95. Ziesenitz VC, Vaughns JD, Koch G, Mikus G, van den Anker JN. Correction to: Pharmacokinetics of fentanyl and its derivatives in children: a comprehensive review. Clin Pharmacokinet. 2018;57: 393-417. Go to original source... Go to PubMed...
  96. O'Neil MJ (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Cambridge, UK: Royal Society of Chemistry; 2013. p. 1643.
  97. Thomson IR, Hudson RJ, Rosenbloom M, Meatherall RC. A randomized double-blind comparison of fentanyl and sufentanil anaesthesia for coronary artery surgery. Can J Anaesth. 1987;34:227-232. Go to original source... Go to PubMed...
  98. Cohen SE, Tan S, White PF. Sufentanil analgesia following cesarean section: epidural versus intravenous administration. Anesthesiology 1988;68:129-134. Go to original source... Go to PubMed...
  99. Sufentanil: Uses, Interactions, Mechanism of Action. [Internet]. [cited 2024 Feb 23]. Available from: https://go.drugbank.com/drugs/DB00708.
  100. Monk JP, Beresford R, Ward A. Sufentanil. Drugs 1988;36:286-313. Go to original source... Go to PubMed...
  101. Fisher DM, Chang P, Wada DR, Dahan A, Palmer PP. Pharmacokinetic properties of a sufentanil sublingual tablet intended to treat acute pain. Anesthesiology 2018;128(5):943-952. Go to original source... Go to PubMed...
  102. Reitz JA. Alfentanil in anesthesia and analgesia. Drug Intell Clin Pharm. 1986;20(5):335-341. Go to original source... Go to PubMed...
  103. Türk HŞ, Aydoğmuş M, Ünsal O, Işil CT, Citgez B, Oba S, Açik ME. Ketamine versus alfentanil combined with propofol for sedation in colonoscopy procedures: a randomized prospective study. Turk J Gastroenterol. 2014;25(6):644-649. Go to original source... Go to PubMed...
  104. Saarnivaara L, Klemola UM. Alfentanil as an adjuvant of balanced anaesthesia for tonsillectomy in adults. Acta Anaesthesiol Scand. 1987;31(1):1-6. Go to original source... Go to PubMed...
  105. Karcioglu M, Davarci I, Tuzcu K, Bozdogan YB, Turhanoglu S, Aydogan A, Temiz M. Addition of ketamine to propofol-alfentanil anesthesia may reduce postoperative pain in laparoscopic cholecystectomy. Surg Laparosc Endosc Percutan Tech. 2013;23(2):197-202. Go to original source... Go to PubMed...
  106. Eberl S, Koers L, van Hooft J, de Jong E, Hermanides J, Hollmann MW, Preckel B. The effectiveness of a low-dose esketamine versus an alfentanil adjunct to propofol sedation during endoscopic retrograde cholangiopancreatography: A randomised controlled multicentre trial. Eur J Anaesthesiol. 2020;37(5):394-401. Go to original source... Go to PubMed...
  107. Klees TM, Sheffels P, Dale O, Kharasch ED. Metabolism of alfentanil by cytochrome p4503a (cyp3a) enzymes. Drug Metab Dispos. 2005;33(3):303-311. Go to original source... Go to PubMed...
  108. Alfentanil - an overview. [Internet]. [cited 2024 Feb 23]. Available from: https://www.sciencedirect.com/topics/medicine-and-dentistry/alfentanil.
  109. O'Neil MJ (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Cambridge, UK: Royal Society of Chemistry; 2013. p. 1509.
  110. Egan TD. Remifentanil pharmacokinetics and pharmacodynamics. A preliminary appraisal. Clin Pharmacokinet. 1995;29(2):80-94. Go to original source... Go to PubMed...
  111. Remifentanil B. [Internet]. [cited 2024 Feb 23]. Available from: https://www.sukl.cz/download/spc/SPC13906.pdf.
  112. Remifentanil: Uses, Interactions, Mechanism of Action. [Internet]. [cited 2024 Feb 23]. Available from: https://go.drugbank.com/drugs/DB00899.
  113. Komatsu R, Turan AM, Orhan-Sungur M, McGuire J, Radke OC, Apfel CC. Remifentanil for general anaesthesia: a systematic review. Anaesthesia 2007;62(12):1266-1280. Go to original source... Go to PubMed...
  114. Torres LM, Calderón E, Velázquez A. Remifentanilo. Indicaciones en anestesia. Rev Esp Anestiol Reanim. 1999;46:75-80.
  115. Philip BK. The use of remifentanil in clinical anesthesia. Acta Anaesthesiol Scand Suppl. 1996;109:170-173. Go to original source...
  116. Hoke JF, Cunningham F, James MK, Muir KT, Hoffman WE. Comparative pharmacokinetics and pharmacodynamics of remifentanil, its principle metabolite (GR90291) and alfentanil in dogs. J Pharmacol Exp Ther. 1997;281(1):226-232. Go to original source...
  117. Beers R, Camporesi E. Remifentanil update: clinical science and utility. CNS Drugs 2004;18(15):1085-1104. Go to original source... Go to PubMed...
  118. Bischoff P, Kochs E. Alpha 2-Agonisten in Anästhesie und Intensivmedizin [Alpha 2-agonists in anesthesia and intensive medicine]. Anasthesiol Intensivmed Notfallmed Schmerzther. 1993;28(1):2-12. Go to original source... Go to PubMed...
  119. Maze M, Tranquilli W. Alpha-2 adrenoceptor agonists: defining the role in clinical anesthesia. Anesthesiology 1991;74(3):581-605. Go to original source...
  120. Kamibayashi T, Maze M. Clinical uses of alpha2-adrenergic agonists. Anesthesiology 2000;93(5):1345-1349. Go to original source... Go to PubMed...
  121. Chen K, Lu Z, Xin YC, Cai Y, Chen Y, Pan SM. Alpha-2 agonists for long-term sedation during mechanical ventilation in critically ill patients. Cochrane Database Syst Rev. 2015;1(1):CD010269. Go to original source... Go to PubMed...
  122. Giovannitti JA Jr, Thoms SM, Crawford JJ. Alpha-2 adrenergic receptor agonists: a review of current clinical applications. Anesth Prog. 2015;62(1):31-39. Go to original source... Go to PubMed...
  123. Duncan D, Sankar A, Beattie WS, Wijeysundera DN. Alpha-2 adrenergic agonists for the prevention of cardiac complications among adults undergoing surgery. Cochrane Database Syst Rev. 2018; 3(3), CD004126. Go to original source... Go to PubMed...
  124. Clonidine. [Internet]. [cited 2024 Feb 23]. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/2803.
  125. Clonidine hydrochloride. [Internet]. [cited 2024 Feb 23]. Available from: http://www.chemspider.com/Chemical-Structure.19006.html.
  126. Clonidine - an overview. [Internet]. [cited 2024 Feb 23]. Available from: https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/clonidine.
  127. Tryba M, Gehling M. Clonidine - a potent analgesic adjuvant. Curr Opin Anaesthesiol. 2002;15(5):511-517. Go to original source... Go to PubMed...
  128. Huber D, Kretz FJ. Clonidin in der Kinderanästhesie [Efficacy of clonidine in paediatric anaesthesia]. Anasthesiol. Intensivmed. Notfallmed Schmerzther. 2005;40(10):567-575. Go to original source... Go to PubMed...
  129. Fresquez-Chavez KR, Fogger S. Reduction of opiate withdrawal symptoms with use of clonidine in a county jail. J Correct Health Care 2015;21(1):27-34. Go to original source... Go to PubMed...
  130. Clonidine: Uses, Interactions, Mechanism of Action [Internet]. [cited 2024 Feb 23]. Available from: https://go.drugbank.com/drugs/DB00575.
  131. Claessens AJ, Risler LJ, Eyal S, Shen DD, Easterling TR, Hebert MF. CYP2D6 mediates 4-hydroxylation of clonidine in vitro: implication for pregnancy-induced changes in clonidine clearance. Drug Metab Dispos. 2010;38(9):1393-1396. Go to original source... Go to PubMed...
  132. Xylazine. [Internet]. [cited 2024 Feb 23]. Available from: http://www.chemspider.com/Chemical-Structure.5505.html.
  133. Xylazine (X1126) - Product Information Sheet. [Internet]. [cited 2024 Feb 23]. Available from: https://www.sigmaaldrich.com/deepweb/assets/sigmaaldrich/product/documents/349/841/x1126pis.pdf.
  134. Xylazine: Uses, interactions, mechanism of action. [Internet]. [cited 2024 Feb 23]. Available from: https://go.drugbank.com/drugs/DB11477.
  135. Papudesi BN, Malayala SV, Regina AC. Xylazine toxicity - StatPearls. In: ncbi.nlm.nih.gov [Internet]. 2023 Jul 17 [cited 2024 Feb 23]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK594271/.
  136. Schmidt-Oechtering GU, Alef M, Röcken M. Ein Beitrag zur Anästhesie des Pferdes mit Xylazin und Ketamin. Teil 2: Die Anästhesie des adulten Pferdes [Anesthesia of horses with xylazine and ketamine. 2. Anesthesia in adult horses]. Tierarztl Prax. 1990;18(1):47-52.
  137. Meyer GM, Maurer HH. Qualitative metabolism assessment and toxicological detection of xylazine, a veterinary tranquilizer and drug of abuse, in rat and human urine using GC-MS, LC-MSn, and LC-HR-MSn. Anal Bioanal Chem. 2013;405(30):9779-9789. Go to original source... Go to PubMed...
  138. Park JW, Chung HW, Lee EJ, Jung KH, Paik JY, Lee KH. α2-Adrenergic agonists including xylazine and dexmedetomidine inhibit norepinephrine transporter function in SK-N-SH cells. Neurosci Lett. 2013;541:184-189. Go to original source... Go to PubMed...
  139. Medetomidine - Chemical Dictionary. [Internet]. [cited 2024 Feb 23]. Available from: https://www.guidechem.com/dictionary/en/86347-14-0.html.
  140. Medetomidine Hydrochloride. [Internet]. [cited 2024 Feb 23]. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/medetomidine%20hydrochloride.
  141. Sinclair MD. A review of the physiological effects of alpha2-agonists related to the clinical use of medetomidine in small animal practiceh. Can Vet J. 2003;44(11):885-897.
  142. Clarke KW. Medetomidine, a new sedative-analgesic for use in the dog and its reversal with atipamezole. J Small Anim Pract. 2008;30(6):343-348. Go to original source...
  143. Virtanen R. Pharmacological profiles of medetomidine and its antagonist, atipamezole. Acta Vet Scand Suppl. 1989;85:29-37.
  144. Medetomidine. [Internet]. [cited 2024 Feb 23]. Available from: https://www.uu.nl/sites/default/files/Medetomidine40mgml_SPC_2021Jul.pdf.
  145. Salonen JS. Pharmacokinetics of medetomidine. Acta Vet Scand Suppl. 1989;85:49-54.
  146. Grimsrud KN, Mama KR, Steffey EP, Stanley SD. Pharmacokinetics and pharmacodynamics of intravenous medetomidine in the horse. Vet Anaesth Analg. 2012;39:38-48. Go to original source... Go to PubMed...
  147. Medetomidine: uses, interactions, mechanism of action. [Internet]. [cited 2024 Feb 23]. Available from: https://go.drugbank.com/drugs/DB11428.
  148. Dexmedetomidine. [Internet]. [cited 2024 Feb 23]. Available from: https://www.chemsrc.com/en/cas/113775-47-6_453242.html.
  149. Dexmedetomidine. [Internet]. [cited 2024 Feb 23]. Available from: https://www.abcam.com/en-mk/products/biochemicals/dexmedetomidine-hydrochloride-alpha2-agonist-ab120767.
  150. Zhao Y, He J, Yu N, Jia C, Wang S. Mechanisms of dexmedetomidine in neuropathic pain. Front Neurosci. 2020;14:330. Go to original source... Go to PubMed...
  151. Arcangeli A, D'Alò C, Gaspari R. Dexmedetomidine use in general anaesthesia. Current Drug Targets 2009;10(8):687-695. Go to original source... Go to PubMed...
  152. Ramsay MA, Luterman DL. Dexmedetomidine as a total intravenous anesthetic agent. Anesthesiology 2004;101(3):787-790. Go to original source... Go to PubMed...
  153. Paris A, Tonner PH. Dexmedetomidine in anaesthesia. Curr Opin Anaesthesiol. 2005;18(4):412-418. Go to original source... Go to PubMed...
  154. Candiotti KA, Bergese SD, Bokesch PM, Feldman MA, Wisemandle W, Bekker AY. Monitored anesthesia care with dexmedetomidine: a prospective, randomized, double-blind, multicenter trial. Anesth Analg. 2010;110:47-56. Go to original source... Go to PubMed...
  155. Abdallah FW, Abrishami A, Brull R. The facilitatory effects of intravenous dexmedetomidine on the duration of spinal anesthesia. Anesth Analg. 2013;117:271-278. Go to original source... Go to PubMed...
  156. Dexmedetomidine: Uses, Interactions, Mechanism of Action. [Internet]. [cited 2024 Feb 23]. Available from: https://go.drugbank.com/drugs/DB00633.
  157. Weerink MAS, Struys MMRF, Hannivoort LN, Barends CRM, Absalom AR, Colin P. Clinical pharmacokinetics and pharmacodynamics of dexmedetomidine. Clin Pharmacokinet. 2017;56(8):893-913. Go to original source... Go to PubMed...
  158. Sugammadex. [Internet]. [cited 2024 Feb 23]. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/Sugammadex.
  159. Nag K, Singh DR, Shetti AN, Kumar H, Sivashanmugam T, Parthasarathy S. Sugammadex: A revolutionary drug in neuromuscular pharmacology. Anesth Essays Res. 2013;7(3):302-306. Go to original source... Go to PubMed...
  160. Hawkins J, Khanna S, Argalious M. Sugammadex for reversal of neuromuscular blockade: uses and limitations. Curr Pharm Des. 2019;25(19):2140-2148. Go to original source... Go to PubMed...
  161. Pancuronium bromide. [Internet]. [cited 2024 Feb 23]. Available from: https://www.chemicalbook.com/ProductMSDSDetailCB7167065_EN.htm.
  162. Das GN, Sharma P, Maani CV. Pancuronium - StatPearls. In: ncbi.nlm.nih.gov [Internet]. 2023 Aug 8 [cited 2024 Feb 23]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK538346/.
  163. Pancuronium: Prescribing Information. [Internet]. [cited 2024 Feb 23]. Available from: https://www.drugs.com/pro/pancuronium.html
  164. Rocuronium Bromide. [Internet]. [cited 2024 Feb 23]. Available from: https://lktlabs.com/product/rocuronium-bromide.
  165. Rocuronium: uses, interactions, mechanism of action. [Internet]. [cited 2024 Feb 23]. Available from: https://go.drugbank.com/drugs/DB00728.
  166. Chetty MS, Pollard BL, Wilson A, Healy TE. Rocuronium bromide in dental day case anaesthesia - a comparison with atracurium and vecuronium. Anaesth Intensive Care 1996;24(1):37-41. Go to original source...
  167. Misra MN, Agarwal M, Pandey RP, Gupta A. A comparative study of rocuronium, vecuronium and succinylcholine for rapid sequence induction of anaesthesia. Indian J Anaesth. 2005;49:469-473.
  168. Khuenl-Brady KS, Sparr H. Clinical pharmacokinetics of rocuronium bromide. Clin Pharmacokinet. 1996;31:174-183. Go to original source... Go to PubMed...
  169. Vecuronium bromide. [Internet]. [cited 2024 Feb 23]. Available from: http://www.afinechem.com/product_detail_kr/id/986.html.
  170. McKenzie AG. Prelude to pancuronium and vecuronium. Anaesthesia 2000;55(6):551-556. Go to original source... Go to PubMed...
  171. Vecuronium - an overview. [Internet]. [cited 2024 Feb 23]. Available from: https://www.sciencedirect.com/topics/medicine-and-dentistry/vecuronium.
  172. Ball C, Westhorpe RN. Muscle relaxants - pancuronium and vecuronium. Anaesth Intensive Care 2006;34(2):137. Go to original source...
  173. Caldwell JE, Szenohradszky J, Segredo V, Wright PM, McLoughlin C, Sharma ML, Gruenke LD, Fisher DM, Miller RD. The pharmacodynamics and pharmacokinetics of the metabolite 3-desacetylvecuronium (ORG 7268) and its parent compound, vecuronium, in human volunteers. J Pharmacol Exp Ther. 1994;270(3):1216-1222. Go to original source...
  174. Ramzy M, McAllister RK. Vecuronium - StatPearls. In: ncbi.nlm.nih.gov [Internet]. 2023 Aug 17 [cited 2024 Feb 23]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK493143.
  175. Suy K, Morias K, Cammu G, Hans P, van Duijnhoven WG, Heeringa M, Demeyer I. Effective reversal of moderate rocuronium- or vecuronium-induced neuromuscular block with sugammadex, a selective relaxant binding agent. Anesthesiology 2007;106(2):283-288. Go to original source... Go to PubMed...
  176. Atracurium besylate. [Internet]. [cited 2024 Feb 23]. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/Atracurium-besylate.
  177. Ritz ML, Derian A. Atracurium - StatPearls. In: ncbi.nlm.nih.gov [Internet]. 2023 Aug 14 [cited 2024 Feb 23]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK499995/.
  178. Cisatracurium - an overview. [Internet]. [cited 2024 Feb 23]. Available from: https://www.sciencedirect.com/topics/medicine-and-dentistry/cisatracurium.
  179. Payne JP. Evaluation of atracurium in anaesthetized man. Br J Anaesth. 1981;53:45. Go to original source...
  180. Hughes R. Atracurium - the first years. Clinics in Anaesthesiology 1985;3(2):331-345. Go to original source...
  181. Slavov V, Khalil M, Merle JC, Agostini MM, Ruggier R, Duvaldestin P. Comparison of duration of neuromuscular blocking effect of atracurium and vecuronium in young and elderly patients. Br J Anaesth. 1995;74:709-711. Go to original source... Go to PubMed...
  182. Vandenbrom RH, Wierda JM, Agoston S. Pharmacokinetics and neuromuscular blocking effects of atracurium besylate and two of its metabolites in patients with normal and impaired renal function. Clin Pharmacokinet. 1990;19(3):230-240. Go to original source... Go to PubMed...
  183. Strawbridge AD, Khanna NR, Patel P, Hauser JM. Cisatracurium - StatPearls. In: ncbi.nlm.nih.gov [Internet]. 2023 Oct 24 [cited 2024 Feb 23]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK539842.
  184. Eastwood NB, Boyd AH, Parker CJ, Hunter JM. Pharmacokinetics of 1R-cis 1'R-cis atracurium besylate (51W89) and plasma laudanosine concentrations in health and chronic renal failure. Br J Anaesth. 1995;75(4):431-435. Go to original source... Go to PubMed...
  185. Fodale V, Santamaria LB. Laudanosine, an atracurium and cisatracurium metabolite. Eur J Anaesthesiol. 2002;19(7):466-473. Go to original source...
  186. Bakhshi R, Nagaria A, Mohite S, Ahluwalia G. Comparison of neuromuscular blockade and recovery characteristics of cisatracurium besylate versus atracurium besylate in adult surgical patients. J Med Sci Clin Res. 2016;4:14613-14621. Go to original source...
  187. Karol MD, Maze M. Pharmacokinetics and interaction pharmacodynamics of dexmedetomidine in humans. Best Pract Res Clin Anaesthesiol. 2000;14:261-269. Go to original source...
  188. Succinylcholine iodide. [Internet]. [cited 2024 Feb 23]. Available from: https://www.drugfuture.com/chemdata/Succinylcholine-Iodide.html.
  189. Succinylcholine. [Internet]. [cited 2024 Feb 23]. Available from: https://go.drugbank.com/drugs/DB00202.
  190. Succinylcholine chloride. [Internet]. [cited 2024 Feb 23]. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/succinylcholine%20chloride.
  191. Lund PC. A clinical evaluation of succinylcholine chloride as a muscle relaxant in anesthesia. Am J Surg. 1953;86(3):312-317. Go to original source... Go to PubMed...
  192. Torda TA, Graham GG, Warwick NR, Donohue P. Pharmacokinetics and pharmacodynamics of suxamethonium. Anaesth Intensive Care 1997;25(3):272-278. Go to original source... Go to PubMed...
  193. Suxamethonium - an overview. [Internet]. [cited 2024 Feb 23]. Available from: https://www.sciencedirect.com/topics/medicine-and-dentistry/suxamethonium.




Czech and Slovak Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.